Cooper CyberKnife Center is a clinical research site located in Mount Laurel, New Jersey, United States 08054.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Cooper CyberKnife Center has participated in 7 clinical trials with 4 currently active.
Therapeutic areas: Locally Advanced Bone Sarcoma, Locally Advanced Dedifferentiated Liposarcoma, Locally Advanced Gastrointestinal Stromal Tumor.
Sponsors: National Cancer Institute (NCI), NRG Oncology, Radiation Therapy Oncology Group.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Cooper CyberKnife Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cooper CyberKnife Center has 7 clinical trials on record, with 4 currently active. Their work covers Locally Advanced Bone Sarcoma, Locally Advanced Dedifferentiated Liposarcoma, Locally Advanced Gastrointestinal Stromal Tumor.
Yes — Cooper CyberKnife Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.